Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: Stem Cell Therapy for Early Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is recruiting to evaluate a stem cell therapy for early Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Paul E Schulz | Conditions: Cognitive Dysfunction | Phase 1, Phase 2 | Status: RECRUITING